From the Departments of Neurosurgery (K.Y., H.I.), Microbiology (M.S.,
T.N.), and Pathology (T.G.), Yamaguchi University School of Medicine,
Yamaguchi, Japan, and the Department of Pediatrics, Saiseikai Shimonoseki
General Hospital (K.O.), Shimonoseki, Japan.
Correspondence to Katsuhiro Yamashita, Department of Neurosurgery, Yamaguchi University School of Medicine, 1144 Kogushi, Ube, Yamaguchi, 755 Japan. E-mail yamasita-ygc{at}umin.u-tokyo.ac.jp
Background and
Purpose—Chlamydia pneumoniae infection has
recently become noteworthy in relation to
atherosclerosis. We investigated by
immunohistochemistry the distribution of C pneumoniae
infection in the atherosclerotic carotid artery.
Methods—Twenty carotid atherosclerotic lesions that were resected
during carotid endarterectomy were investigated.
Parallel sections were stained immunohistochemically with monoclonal
antibodies for a C pneumoniae–specific antigen,
macrophages, and smooth muscle cells.
Results—Immunoreactivity for the C
pneumoniae–specific antigen was observed in 11 of 20 specimens
(55%), and intense immunoreactivity was observed in 7 of 20 (35%).
C pneumoniae infection was observed in
endothelial cells, macrophages and in smooth
muscle cells that had migrated into the atheromatous
plaque, as well as in smooth muscle cells and small arteries in the
media underlying the atheromatous plaques. C
pneumoniae infection was most prominently observed in smooth
muscle cells. The severity of the infection as demonstrated by
immunohistochemistry was not significantly related to general risk
factors for atherosclerosis.
Conclusions—C pneumoniae widely infects
endothelial cells, macrophages, and smooth
muscle cells in the atherosclerotic carotid artery. The results of the
present study can help us to understand how C
pneumoniae infection contributes to the progression of carotid
atherosclerosis.
© 1998 American Heart Association, Inc.
Original Contributions
Distribution of Chlamydia pneumoniae Infection in the Atherosclerotic Carotid Artery
Key Words: atherosclerosis • carotid arteries • Chlamydia pneumoniae • infection
This article has been cited by other articles:
 |
|
 |
|
  H. Ustunsoy, C. Sivrikoz, F. Sirmatel, K. Bakir, O. Burma, and H. Kazaz Is Chlamydia Pneumoniae a Risk Factor for Peripheral Atherosclerosis? Asian Cardiovasc Thorac Ann, February 1, 2007; 15(1): 9 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.J. Ford, E. Gemmell, P. Timms, A. Chan, F.M. Preston, and G.J. Seymour Anti-P. gingivalis Response Correlates with Atherosclerosis Journal of Dental Research, January 1, 2007; 86(1): 35 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Stoll and M. Bendszus Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization Stroke, July 1, 2006; 37(7): 1923 - 1932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Yang, D. Coriolan, K. Schultz, D. T. Golenbock, and D. Beasley Toll-Like Receptor 2 Mediates Persistent Chemokine Release by Chlamydia pneumoniae-Infected Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2308 - 2314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ford, E. Gemmell, P. Walker, M. West, M. Cullinan, and G. Seymour Characterization of Heat Shock Protein-Specific T Cells in Atherosclerosis Clin. Vaccine Immunol., February 1, 2005; 12(2): 259 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fisher, A. Paganini-Hill, A. Martin, M. Cosgrove, J. F. Toole, H. J.M. Barnett, and J. Norris Carotid Plaque Pathology: Thrombosis, Ulceration, and Stroke Pathogenesis Stroke, February 1, 2005; 36(2): 253 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rodel, D. Prochnau, K. Prager, J. Baumert, K.-H. Schmidt, and E. Straube Chlamydia pneumoniae Decreases Smooth Muscle Cell Proliferation through Induction of Prostaglandin E2 Synthesis Infect. Immun., August 1, 2004; 72(8): 4900 - 4904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hirono, E. Dibrov, C. Hurtado, A. Kostenuk, R. Ducas, and G. N. Pierce Chlamydia pneumoniae Stimulates Proliferation of Vascular Smooth Muscle Cells Through Induction of Endogenous Heat Shock Protein 60 Circ. Res., October 17, 2003; 93(8): 710 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Lindsberg and A. J. Grau Inflammation and Infections as Risk Factors for Ischemic Stroke Stroke, October 1, 2003; 34(10): 2518 - 2532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kocazeybek Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study J. Med. Microbiol., August 1, 2003; 52(8): 721 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yoneda, K. Miura, H. Matsushima, K. Sugi, T. Murakami, K. Ouchi, K. Yamashita, H. Itoh, T. Nakazawa, M. Suzuki, et al. Aspirin inhibits Chlamydia pneumoniae-induced NF-{kappa}B activation, cyclo-oxygenase-2 expression and prostaglandin E2 synthesis and attenuates chlamydial growth J. Med. Microbiol., May 1, 2003; 52(5): 409 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V Pislaru, M. Van Ranst, C. Pislaru, Z. Szelid, G. Theilmeier, J.M Ossewaarde, P. Holvoet, S. Janssens, E. Verbeken, and F. J Van de Werf Chlamydia pneumoniae induces neointima formation in coronary arteries of normal pigs Cardiovasc Res, March 1, 2003; 57(3): 834 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Stollberger and J. Finsterer Role of Infectious and Immune Factors in Coronary and Cerebrovascular Arteriosclerosis Clin. Vaccine Immunol., March 1, 2002; 9(2): 207 - 215. [Full Text] [PDF]
|
|
|
|
|
|
P. B. Gorelick Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review Stroke, March 1, 2002; 33(3): 862 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lavallee, V. Perchaud, M. Gautier-Bertrand, D. Grabli, and P. Amarenco Association Between Influenza Vaccination and Reduced Risk of Brain Infarction Stroke, February 1, 2002; 33(2): 513 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Boman and M. R. Hammerschlag Chlamydia pneumoniae and Atherosclerosis: Critical Assessment of Diagnostic Methods and Relevance to Treatment Studies Clin. Microbiol. Rev., January 1, 2002; 15(1): 1 - 20. [Abstract] [Full Text]
|
|
|
|
|
|
Z. G. Nadareishvili, D. E. Koziol, B. Szekely, C. Ruetzler, R. LaBiche, R. McCarron, T. J. DeGraba, and S. Jander Increased CD8+ T Cells Associated With Chlamydia pneumoniae in Symptomatic Carotid Plaque Editorial Comment Stroke, September 1, 2001; 32(9): 1966 - 1972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Goldstein, R. Adams, K. Becker, C. D. Furberg, P. B. Gorelick, G. Hademenos, M. Hill, G. Howard, V. J. Howard, B. Jacobs, et al. Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association Circulation, January 2, 2001; 103(1): 163 - 182. [Full Text] [PDF]
|
|
|
|
|
|
L. B. Goldstein, R. Adams, K. Becker, C. D. Furberg, P. B. Gorelick, G. Hademenos, M. Hill, G. Howard, V. J. Howard, B. Jacobs, et al. Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association Stroke, January 1, 2001; 32(1): 280 - 299. [Full Text] [PDF]
|
|
|
|
 |
|
 S A Morre, W Stooker, W K Lagrand, A J C van den Brule, and H W M Niessen Microorganisms in the aetiology of atherosclerosis J. Clin. Pathol., September 1, 2000; 53(9): 647 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schmidt, J. Hulthe, J. Wikstrand, H. Gnarpe, J. Gnarpe, S. Agewall, and B. Fagerberg Chlamydia pneumoniae Seropositivity Is Associated With Carotid Artery Intima-Media Thickness Stroke, July 1, 2000; 31(7): 1526 - 1531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rodel, M. Woytas, A. Groh, K.-H. Schmidt, M. Hartmann, M. Lehmann, and E. Straube Production of Basic Fibroblast Growth Factor and Interleukin 6 by Human Smooth Muscle Cells following Infection with Chlamydia pneumoniae Infect. Immun., June 1, 2000; 68(6): 3635 - 3641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shor and J. I. Phillips Chlamydia pneumoniae and Atherosclerosis JAMA, December 1, 1999; 282(21): 2071 - 2073. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Cook Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma J. Antimicrob. Chemother., August 1, 1999; 44(2): 145 - 148. [Full Text] [PDF]
|
|
|
|
|
|
S. Sasu, D. LaVerda, N. Qureshi, D. T. Golenbock, and D. Beasley Chlamydia pneumoniae and Chlamydial Heat Shock Protein 60 Stimulate Proliferation of Human Vascular Smooth Muscle Cells via Toll-Like Receptor 4 and p44/p42 Mitogen-Activated Protein Kinase Activation Circ. Res., August 3, 2001; 89(3): 244 - 250. [Abstract] [Full Text] [PDF]
|
|